International Myeloma Foundation press release: iStopMM charts the way forward in Myeloma research and treatment. This year, iStopMM presents four oral abstracts and two posters at the American Society of Hematology (ASH) Annual Meeting held in Atlanta December 11-14. The Annual Meeting presents the newest advances in malignant and non-malignant hematology and provides a good opportunity for global networking in the community of hematologists.
High prevalence of smoldering myeloma observed in nationwide screening study
In an article in CancerTherapyAdvisor.com the iStopMM study and it‘s results are covered. Results from the study were presented at the 2021 American Society of